Skip to main content

Table 1 Published studies evaluating doses of oxytocin (syntocinon)

From: Study Protocol. ECSSIT – Elective Caesarean Section Syntocinon® Infusion Trial. A multi-centre randomised controlled trial of oxytocin (Syntocinon®) 5 IU bolus and placebo infusion versus oxytocin 5 IU bolus and 40 IU infusion for the control of blood loss at elective caesarean section

Author, citation

Study design

Exposures

Outcome measures

Results

Conclusions

Sarna MC et al

Anesth Analg 1997

84:753–6.

RCT

40 women

Elective CS/regional

Oxytocin after cord clamping

5 IU vs 10 IU vs 15 IU vs 20 IU

Linear analogue of uterine tone

EBL

ΔHCT (pre-op/post-op)

No difference in any outcomes

No benefit in doses exceeding 5 IU

Zarzur

Anesth Analg 1998

86:1334.

Dose-finding

20 women

Elective CS

Oxytocin dosing

Uterine contractility

Side effects

3 IU oxytocin

Satisfactory

No side effects

Low dose 3 IU sufficient

Carvalho JC et al

Obstet Gynecol 2004

104:1005–10.

Dose-finding

RCT single blind

40 women

Elective CS/regional

Titrating increments of 0.5 IU oxytocin bolus

Infusion 2.4 IU/hr

Minimum effective dose ED

Uterine contraction

EBL (calculated)

ED90 at 0.35 IU

100% at 1.0 IU

Low dose bolus < 5 IU effective

Balki M et al

Obstet Gynecol 2006

107:45–50.

Dose-finding

RCT single blind

30 women

CS for labor arrest

Titrating increments of 0.5 IU oxytocin bolus

Infusion 2.4 IU/hr

Minimum effective dose ED

Uterine contraction

EBL (calculated)

ED90 at 3.0 IU

Much higher dose than for elective CS

Suggest alternative agent for non-elective